X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-27 | SCTX | Ah Bio Fund Ii, L.P. | 10% | P - Purchase | $15.00 | +333,333 | 3,082,725 | +12% | +$4,999,995 | |||||
| D | 2026-07-27 | SCTX | Gordon Carl L | Dir | P - Purchase | $15.00 | +1,000,000 | 1,348,825 | +287% | +$15,000,000 | |||||
| D | 2026-07-27 | SCTX | Orbimed Advisors LLC | Dir | P - Purchase | $15.00 | +1,000,000 | 1,348,825 | +287% | +$15,000,000 | |||||
| M | 2026-07-24 | SCTX | Aghazadeh Behzad | See Remarks, 10% | P - Purchase | $15.16 | +2,391,238 | 3,088,888 | +343% | +$36,259,761 | |||||
| D | 2026-07-23 | SCTX | Lucas Svetlana | Chief Business Officer | P - Purchase | $15.00 | +3,000 | 3,000 | New | +$45,000 | |||||
| D | 2026-07-23 | SCTX | Parrot David | CFO | P - Purchase | $15.00 | +2,666 | 2,666 | New | +$39,990 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |